THE NEW AMERICAN DIVISION OF KALMS CONSULTING/
PROVIDING AMERICAN FIRMS FASTER ACCESS TO THE EUROPEAN HEALTH CARE MARKET
Kalms Consulting is pleased to announce that it is opening two new American of ces in the most vi- brant healthcare technology regions of the United States: San Francisco and Minneapolis.
Navigating FDA approval can be a signi cant in- vestment in time and dollars. Executing a dual pathway strategy via the European market can provide a streamlined opportunity that quickly al- lows manufacturers to jumpstart revenue gains, develop a strong health economics story, and ag- gregate additional clinical data needed to success- fully gain approval in the U.S. The European mar- ket is also an attractive target for well-established companies looking to expand beyond their native country. Kalms Consulting enjoys longstanding re- lationships with small, mid-cap and large, US-based medical device, biotech, biopharma and life science clients who continue to bene t from broadening their revenue pathways in Europe. Establishing permanent of ces in the United States to better serve existing and future clients made perfect sense. The Kalms Consulting team is comprised of experienced and highly quali ed experts who deliver affordable, data-driven solutions to clients worldwide. The U.S. division will speci cally focus its efforts on market access, strategic business development, technology assessment and market analysis while working in concert with their European counterparts.
Founder & CEO
“It is my pleasure to introduce the American Division of Kalms Consulting. With these of ces we’re giving American rms a better opportunity to access the German and European market.”
Kalms Consulting GmbH
Rheinstrasse 45–46 Aufgang 1
12161 Berlin | GERMANY
KALMS CONSULTING SAN FRANCISCO/
HEALTH CARE IS THE BIGGEST INDUSTRY IN THE BAY AREA
San Francisco is the cultural, commercial, and financial center of Northern California.
California has a great history of innovation in life sciences, developing new technologies to solve health problems.
As the birthplace of biotechnology California stands for the innovation in life sciences in particular. Genomic technologies help detect diseases, while new therapies and devices help to treat them. Digital health technologies help prevent diseases and provide patients with better tools to manage their con- ditions.
Life Sciences is a cornerstone of California’s econ- omy and contributes to a healthier society and advances new medical technologies.
California’s life sciences community continues to grow, with 3,040 life sciences companies – 192 more than the previous year – producing new technolo- gies and boosting the state’s economy. In 2015, the Golden State’s life sciences industry employed more than 287,000 people. This highly trained and diverse workforce helped develop novel drugs, devices and diagnostics, while also exploring other applications, such as leveraging biotechnology to produce sustainable energy. “Life sciences companies have been incredibly successful. As of September 7, 2016, 1,269 drugs from Californian companies were in the FDA pipeline. In 2015, 264 new devices developed by Californian companies were approved. Academic excellence, forward-thinking public policy and the commitment of thousands of entrepreneurs and business leaders has translated into new ways to address some of the world’s most severe medical conditions: cancer, hepatitis, HIV, rare diseases and many others. These efforts help power our economy and provide health for millions around the world.”1
1CLSA California Life Sciences Association/ 2017 California Life Sciences Industry Report
Business Development U.S.
“Being the center of technological innovation on the West Coast San Francisco is the perfect loca- tion for opening a Kalms Consult- ing of ce. We are going to provide start ups with easier access to the rich European market.”
Kalms Consulting US, Inc.
San Francisco Office
101 Montgomery Street Suite 2050
San Francisco | CA 94104
KALMS CONSULTING MINNEAPOLIS/
A HEALTH AND MEDICAL INDUSTRY HUB WITH TRADITION
Minneapolis is the county seat of Hennepin County, and the larger of the Twin Cities.
Minneapolis and Saint Paul anchor the second-larg- est economic center in the Midwest, after Chicago. Minneapolis lies on both banks of the Mississippi River, just north of the river’s con uence with the Minnesota River, and adjoins Saint Paul, the state’s capital. The city is abundantly rich in water, with thirteen lakes, wetlands, the Mississippi River, creeks and waterfalls.
Minneapolis has a great tradition of making an im- pact on the health eld and continues to do that today. It hosts the University of Minnesota, which ranks in the top three research universities in the USA. Medical device research is robust at the University of Minnesota. One of the most innovative health providers in the nation, Mayo Clinic, is just an hour and a half drive to the south in Rochester.
Multiple Fortune 500 companies in the health eld were founded in Minneapolis, and the impression these companies have left via innovations reverberates throughout the world.
According to the Minnesota-based Medical Alley Association more than two-thirds of last year’s PMAs out of FDA went to applicants out of Califor- nia and Minnesota.
Business Development U.S.
“With Minneapolis’ history of Medical Innovation and achieve- ment the founding of the Minneapolis division of Kalms Consulting will provide existing rms and start ups a gateway to the international stage.”
Business Development U.S.
“The location of Minneapolis in the midwest region provides easy access to rms in Cleveland, Madison and Milwaukee.”
Kalms Consulting US, Inc.
701 N. 3rd Street
Suite 202 | North Loop Minneapolis | MN 55401
GERMANY FIRST, AMERICA SECOND?
TAKING THE FASTER ROUTE TO MARKET FOR HEALTH CARE COMPANIES
May 23rd, 2017 | wework Transbay | San Francisco
An expert panel discussion about what challenges healthcare companies will face, but the experts also addressed the rewards that lie in international expansion. What is the best way to set up a com- pany, how do you go about reimbursements and tax issues? For those in the initial planning phase of expansion there was a general discussion about strategic decisions a healthcare company needs to make when discovering new markets and how to approach this. Michael Kauch, Associate Partner Strategy & Public Affairs to Kalms explained in his talk the current situation of “Reimbursement and devel- opments in Health Policy in Germany“. The panel discussed key factors for succeeding and investing in the German market as a starting point for further international expansion.
Organized by: Kalms Consulting, Osborne Clarke, Rueter und Partner, Invest in Bavaria and GACC
KALMS CONSULTING SUPPORTING VISITS OF
GERMAN BUSINESS DELEGATIONS TO INTUITIVE SURGICAL
May 25th, 2017 | Intuitive Headquarter | Sunnyvale
Supported by Kalms Consulting, high level German business delegations have visited our client Intui- tive Surgical in the headquarter in Sunnyvale, Cali- fornia. 60 entrepreneurs, VC companies and supporting agencies were part of the Silicon Valley tour of the German start-up association (Bundesverband Deutsche Startups). Also the German Ministry of Economic Affairs had been represented. Furthermore, a delegation of the Vodafone Enterprise Fo- rum, led by a Vodafone Germany board member, came to see the latest technological developments in robotic assisted surgery. Both groups were im- pressed how Intuitive Surgical has made its way from a start-up to a market leader - and how Intuitive Surgical is constantly improving its technolo- gies for the bene t of surgeons, hospitals and pa- tients.